|
Market Cap | 24.68M | EPS (ttm) | 5.69 |
P/E | 0.33 | EPS this Y | -110.17% |
Forward P/E | - | EPS next Y | 58.14% |
PEG | - | EPS past 5Y | - |
P/S | 0.13 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 654.07% |
Dividend | - | Sales Q/Q | -13.59% |
Insider Own | - | Inst Own | 19.21% |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | Mar 14/a |
Analyst Recom | 1.00 | Target Price | 5.00 |
Avg Volume | 84.36K | 52W Range | 1.83 - 12.00 |
|
|
|
Urgent.ly, Inc. develops a mobile application for roadside assistance. The firm?s industry solutions include insurance, automotive, financial, parking, wireless, fleets and rental. It specializes in on demand mobile services, mobile apps, mobile web, roadside assistance, towing services, and global digital roadside assistance solutions. The company was founded by Ric Fleisher, Surendra Goel, Luke Kathol, Lokesh Kumar, Rick Robinson and Christopher Spanos in 2013 and is headquartered in Vienna, VA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ben Volkow | Director | Mar 19 '24 | Sale | 2.21 | 2,578 | 5,687 | 559,944 | Mar 21 05:49 PM | Ben Volkow | Director | Mar 18 '24 | Sale | 2.22 | 24,500 | 54,378 | 562,522 | Mar 21 05:49 PM | Ben Volkow | Director | Dec 12 '23 | Sale | 3.43 | 4,278 | 14,674 | 587,022 | Dec 14 06:09 PM | Geisse Andrew M | Director | Nov 17 '23 | Buy | 3.99 | 25,000 | 99,818 | 61,046 | Nov 21 09:00 PM | Pollock Ryan | Director | Oct 19 '23 | Option Exercise | 0.09 | 151,109 | 13,600 | 513,323 | Oct 23 09:21 PM |
|
|
|
|
Market Cap | 2.37B | EPS (ttm) | 3.32 |
P/E | 15.21 | EPS this Y | 12.41% |
Forward P/E | 11.02 | EPS next Y | 5.69% |
PEG | 1.35 | EPS past 5Y | 10.56% |
P/S | 1.82 | EPS next 5Y | 11.29% |
P/B | 2.88 | EPS Q/Q | 17.51% |
Dividend | - | Sales Q/Q | 6.41% |
Insider Own | 11.62% | Inst Own | 93.18% |
Insider Trans | 0.00% | Inst Trans | 2.19% |
Short Float | 1.27% | Earnings | Jan 18/b |
Analyst Recom | 1.17 | Target Price | 77.40 |
Avg Volume | 358.61K | 52W Range | 49.94 - 94.96 |
|
|
|
WNS (Holdings) Ltd. engages in the provision of business process management solutions. Its services include industry-specific offerings, customer interaction, finance and accounting, human resources, procurement, and research and analytics. It operates through the WNS Global BPM and WNS Auto Claims BPM segments. The WNS Global BPM is delivered out of its delivery centers in China Costa Rica, India, the Philippines, Poland, Romania, South Africa, Sri Lanka, the United Kingdom, and the U.S. The WNS Auto Claims BPM segment offers fault and non-fault repairs and legal services in relation to personal injury claims. The company was founded by Alan Stephen Dunning, David Charles Tibble and Neeraj Bhargava on February 18, 2002 and is headquartered in Mumbai, India. |
|
|
|
Market Cap | 1.13M | EPS (ttm) | -76.57 |
P/E | - | EPS this Y | 11.41% |
Forward P/E | - | EPS next Y | -4.75% |
PEG | - | EPS past 5Y | 42.24% |
P/S | - | EPS next 5Y | - |
P/B | 0.39 | EPS Q/Q | -120.70% |
Dividend | - | Sales Q/Q | - |
Insider Own | 7.84% | Inst Own | 2.08% |
Insider Trans | 0.00% | Inst Trans | -69.56% |
Short Float | 6.34% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 300.00 |
Avg Volume | 246.76K | 52W Range | 2.03 - 86.81 |
|
|
|
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Walsh Deina H | Chief Financial Officer | Sep 13 '23 | Buy | 0.64 | 8,000 | 5,120 | 15,000 | Sep 14 11:08 AM | Frelick Jeff | Chief Executive Officer | Sep 11 '23 | Buy | 0.69 | 9,500 | 6,530 | 17,204 | Sep 12 11:34 AM | Walsh Deina H | Chief Financial Officer | Sep 06 '23 | Buy | 0.71 | 7,000 | 4,967 | 7,000 | Sep 07 10:45 AM | Frelick Jeff | Chief Executive Officer | Aug 31 '23 | Buy | 0.66 | 7,600 | 5,020 | 7,704 | Sep 05 05:05 PM |
|
|
| |
|
Market Cap | 2.83B | EPS (ttm) | 0.63 |
P/E | 10.64 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 2.58% |
P/S | 0.64 | EPS next 5Y | - |
P/B | 1.02 | EPS Q/Q | 37.62% |
Dividend | - | Sales Q/Q | 4.94% |
Insider Own | - | Inst Own | 0.79% |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 74.69K | 52W Range | 6.74 - 8.25 |
|
|
Jan-21-24 08:33AM
|
16 Most Profitable New Stocks Today
(Insider Monkey) |
|
Companhia Paranaense de Energia engages in the generation, transmission, distribution and sale of electricity. It operates through the following segments: Power Generation and Transmission (GET), Power Distribution (DIS), Telecommunications (TEL), GAS, Power Sale (COM), and Holding Company (HOL). The GET segment include production of electricity from hydraulic, wind, and thermal projects (GER) and also provides services of transmission and transformation of electric power. The DIS segment comprises public electricity distribution services. The TEL segment offers telecommunications and general communication services. The GAS segment encompasses public service of piped natural gas distribution. The HOL segment participate in other companies. The company was founded on October 26, 1954 and is headquartered in Curitiba, Brazil. |
|
|
|
Market Cap | 4.34M | EPS (ttm) | 1.94 |
P/E | 0.91 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -62.50% |
P/S | 1.31 | EPS next 5Y | - |
P/B | 0.12 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.02% | Inst Own | 2.56% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 5.67% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 520.00 |
Avg Volume | 1.09M | 52W Range | 1.73 - 23.66 |
|
|
|
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel. |
|
| |
|
Market Cap | 145.97M | EPS (ttm) | -0.15 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 20.26% |
P/S | - | EPS next 5Y | - |
P/B | 1.15 | EPS Q/Q | -94.90% |
Dividend | - | Sales Q/Q | - |
Insider Own | 3.67% | Inst Own | 8.33% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.93% | Earnings | Jan 16/b |
Analyst Recom | 1.00 | Target Price | 4.77 |
Avg Volume | 477.11K | 52W Range | 0.66 - 2.49 |
|
|
|
American Lithium Corp. is an exploration stage company. It engages in the acquisition, exploration, and development of lithium deposits. The firm is focused on exploring and developing the TLC Lithium, Falchani Lithium, and Macusani Uranium projects. The company was founded on February 25, 1974 and is headquartered in Vancouver, Canada. |
|
|
|
Market Cap | 1.33B | EPS (ttm) | -2.80 |
P/E | - | EPS this Y | -78.59% |
Forward P/E | - | EPS next Y | 12.22% |
PEG | - | EPS past 5Y | 6.83% |
P/S | 14.56 | EPS next 5Y | 34.07% |
P/B | 2.37 | EPS Q/Q | -1169.13% |
Dividend | - | Sales Q/Q | -99.37% |
Insider Own | 13.65% | Inst Own | 98.80% |
Insider Trans | -0.39% | Inst Trans | -4.11% |
Short Float | 13.47% | Earnings | Feb 15/a |
Analyst Recom | 1.40 | Target Price | 67.78 |
Avg Volume | 827.68K | 52W Range | 24.28 - 79.65 |
|
|
|
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Walker Karin L | Chief Accounting Officer | Jan 24 '24 | Option Exercise | 13.53 | 5,000 | 67,650 | 5,000 | Jan 24 07:01 PM | Walker Karin L | Chief Accounting Officer | Jan 24 '24 | Sale | 34.00 | 5,000 | 170,000 | 0 | Jan 24 07:01 PM | Walker Karin L | Chief Accounting Officer | Dec 20 '23 | Option Exercise | 13.53 | 5,000 | 67,650 | 5,000 | Dec 20 07:17 PM | Walker Karin L | Chief Accounting Officer | Dec 20 '23 | Sale | 37.19 | 5,000 | 185,952 | 0 | Dec 20 07:17 PM | Walker Karin L | Chief Accounting Officer | Nov 30 '23 | Option Exercise | 13.53 | 5,000 | 67,650 | 5,000 | Nov 30 06:24 PM |
|
|
|
|